JP2008534533A5 - - Google Patents

Download PDF

Info

Publication number
JP2008534533A5
JP2008534533A5 JP2008503397A JP2008503397A JP2008534533A5 JP 2008534533 A5 JP2008534533 A5 JP 2008534533A5 JP 2008503397 A JP2008503397 A JP 2008503397A JP 2008503397 A JP2008503397 A JP 2008503397A JP 2008534533 A5 JP2008534533 A5 JP 2008534533A5
Authority
JP
Japan
Prior art keywords
administration system
steroid hormone
administration
steroid
ment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008503397A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008534533A (ja
JP5843416B2 (ja
Filing date
Publication date
Priority claimed from DE102005015128A external-priority patent/DE102005015128B4/de
Application filed filed Critical
Publication of JP2008534533A publication Critical patent/JP2008534533A/ja
Publication of JP2008534533A5 publication Critical patent/JP2008534533A5/ja
Application granted granted Critical
Publication of JP5843416B2 publication Critical patent/JP5843416B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2008503397A 2005-03-31 2006-03-15 ステロイドホルモンを含むタブレット Expired - Fee Related JP5843416B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102005015128.0 2005-03-31
DE102005015128A DE102005015128B4 (de) 2005-03-31 2005-03-31 Wafer enthaltend Steroidhormone
PCT/EP2006/002358 WO2006102990A2 (de) 2005-03-31 2006-03-15 Wafer enthaltend steroidhormone

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013087238A Division JP2013155190A (ja) 2005-03-31 2013-04-18 ステロイドホルモンを含むタブレット

Publications (3)

Publication Number Publication Date
JP2008534533A JP2008534533A (ja) 2008-08-28
JP2008534533A5 true JP2008534533A5 (enExample) 2009-04-09
JP5843416B2 JP5843416B2 (ja) 2016-01-13

Family

ID=36998911

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008503397A Expired - Fee Related JP5843416B2 (ja) 2005-03-31 2006-03-15 ステロイドホルモンを含むタブレット
JP2013087238A Pending JP2013155190A (ja) 2005-03-31 2013-04-18 ステロイドホルモンを含むタブレット

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013087238A Pending JP2013155190A (ja) 2005-03-31 2013-04-18 ステロイドホルモンを含むタブレット

Country Status (26)

Country Link
US (2) US9763960B2 (enExample)
EP (1) EP1863444B1 (enExample)
JP (2) JP5843416B2 (enExample)
KR (2) KR20140063740A (enExample)
CN (2) CN104983669B (enExample)
AR (1) AR054245A1 (enExample)
AU (1) AU2006228820B2 (enExample)
BR (1) BRPI0609601A2 (enExample)
CA (1) CA2598892C (enExample)
CR (1) CR9468A (enExample)
DE (1) DE102005015128B4 (enExample)
DO (1) DOP2006000070A (enExample)
EA (1) EA014183B1 (enExample)
GT (1) GT200600126A (enExample)
IL (1) IL186081A0 (enExample)
MX (1) MX2007012081A (enExample)
NO (1) NO20075404L (enExample)
NZ (1) NZ592882A (enExample)
PE (1) PE20061194A1 (enExample)
SG (1) SG179459A1 (enExample)
SV (1) SV2008002466A (enExample)
TW (1) TWI393576B (enExample)
UA (1) UA92011C2 (enExample)
UY (1) UY29441A1 (enExample)
WO (1) WO2006102990A2 (enExample)
ZA (1) ZA200706116B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8492369B2 (en) 2010-04-12 2013-07-23 Clarus Therapeutics Inc Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
CA2604943C (en) 2005-04-15 2013-09-17 Clarus Therapeutics, Inc. Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
DE102006027796A1 (de) * 2006-06-16 2007-12-20 Lts Lohmann Therapie-Systeme Ag Estrogen-Gestagen-Kombinationen
BRPI0908477A2 (pt) * 2008-02-13 2018-03-27 Bayer Schering Pharma Ag sistema de distribuição de medicamento contendo estradiol
EP2252261A2 (en) * 2008-02-13 2010-11-24 Bayer Schering Pharma Aktiengesellschaft Drug delivery system with stabilising effect
TW201008569A (en) * 2008-08-08 2010-03-01 Bayer Schering Pharma Ag Progestin-containing drug delivery system
WO2010057594A1 (en) * 2008-11-21 2010-05-27 Bayer Schering Pharma Aktiengesellschaft Drug delivery system
DK2493457T3 (en) 2009-10-30 2017-10-02 Ix Biopharma Ltd QUICK-SOLVING SOLID DOSAGE FORM
US12186426B2 (en) 2009-10-30 2025-01-07 Ix Biopharma Ltd. Solid dosage form
US10806703B2 (en) * 2012-01-20 2020-10-20 Lts Lohmann Therapie-System Ag Transmucosal administration system for a pharmaceutical drug
WO2014018075A1 (en) 2012-07-23 2014-01-30 Crayola, Llc Dissolvable films and methods of using the same
DE102017112527B4 (de) * 2017-06-07 2019-01-03 Lts Lohmann Therapie-Systeme Ag Schnell zerfallende Schaumwafer mit hohem Flächengewicht
CA3090262A1 (en) * 2018-02-02 2019-08-08 Aytu Bioscience, Inc. Methods of testosterone therapy
US11564933B2 (en) 2019-04-12 2023-01-31 Tolmar, Inc. Methods of treating testosterone deficiency

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB981372A (en) * 1960-05-04 1965-01-27 Pfizer Ltd Pharmaceutical formulations for oral administration to animals
US4136162A (en) * 1974-07-05 1979-01-23 Schering Aktiengesellschaft Medicament carriers in the form of film having active substance incorporated therein
US4764378A (en) * 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
ES2105262T3 (es) * 1992-05-18 1997-10-16 Minnesota Mining & Mfg Dispositivo de suministro de farmaco a traves de las mucosas.
DE19646392A1 (de) 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
DE19847252B4 (de) * 1998-10-02 2004-02-12 Jenapharm Gmbh & Co. Kg Bukkal applizierbare bioadhäsive Systeme mit zeitlich gesteuerter Wirkstofffreisetzung enthaltend Testosteronester und fakultativ zusätzlich Testosteron
US6552024B1 (en) * 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
US6264981B1 (en) * 1999-10-27 2001-07-24 Anesta Corporation Oral transmucosal drug dosage using solid solution
US20030092658A1 (en) * 2001-02-02 2003-05-15 Meyers Rachel E. Novel human enzyme family members and uses thereof
AU2001273231A1 (en) * 2000-07-06 2002-01-21 Delsys Pharmaceutical Corporation Method for formulating healthcare products with enhanced stability
GB0100760D0 (en) * 2001-01-11 2001-02-21 Biocompatibles Ltd Drug delivery from stents
US6585997B2 (en) * 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
FR2832311B1 (fr) * 2001-11-21 2004-04-16 Besins Int Belgique Poudre filmogene, compositions la comprenant, leurs procedes de preparation et leurs utilisations
JO2492B1 (en) * 2003-04-28 2009-10-05 شيرينج ايه جي A pharmaceutical formula in the form of aqueous gel for the skin use of its active ingredients
WO2005011617A2 (en) * 2003-07-31 2005-02-10 Ivax Corporation Transmucosal dosage forms for brain-targeted steroid chemical delivery systems
ATE534373T1 (de) * 2003-10-10 2011-12-15 Antares Pharma Ipl Ag Transdermale pharmazeutische formulierung zur minimierung von rückständen auf der haut

Similar Documents

Publication Publication Date Title
JP2008534533A5 (enExample)
US5676968A (en) Transdermal therapeutic systems with crystallization inhibitors
AU712692B2 (en) Transdermal therapeutic systems containing crystallization inhibitors
JP2013155190A (ja) ステロイドホルモンを含むタブレット
JP2005500299A5 (enExample)
TW200808382A (en) Film-shaped drug forms for use in the oral cavity (wafers)
JP4132679B2 (ja) 経皮系のための作用物質含有ラミネート
JP2011511816A (ja) 安定化効果を有する薬物送達システム
JP2019517497A5 (enExample)
JP2019123756A (ja) 抗黄体ホルモンの無毒送達のための組成物および方法
US20120245552A1 (en) Combination Therapy
JP2020530461A (ja) 酢酸アビラテロン及びダルロタミドを含む医薬組成物
JP2011506607A (ja) 免疫炎症性障害の処置のための治療法
JP2014508809A5 (enExample)
CN108606963B (zh) 含有屈螺酮和雌激素的复方避孕贴、制备方法及应用
JP2008534566A5 (enExample)
IE20150140A1 (en) Use of antagonists to the nuclear steroid receptor alone or in combination as direct antiviral agents to inhibit alphavirus, togaviridae, arenaviridae, filoviridae, bunyaviridae, flaviviridae and rhabdoviridae
TW200534866A (en) Compositions and methods of enhanced transdermal delivery of steroid compounds and preparation methods thereof
JP2004506006A (ja) 輸送剤としてのステロイドホルモン